Exact Mass: 419.2494012000001

Ethamoxytriphetol

C27H33NO3 (419.2460308000001)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists

Dehydroxypaxilline

C27H33NO3 (419.2460308000001)

Dehydroxypaxilline is a metabolite of Emericella striata. Metabolite of Emericella striata

Hericerin

C27H33NO3 (419.2460308000001)

Hericerin is found in mushrooms. Hericerin is isolated from the edible lions mane mushroom (Hericium erinaceum). Isolated from the edible lions mane mushroom (Hericium erinaceum). Hericerin is found in mushrooms. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

N-Formyl-Nle-Leu-Phe

C22H33N3O5 (419.24200880000006)

N-(2-Carboxyphenyl)retinamide

C27H33NO3 (419.2460308000001)

Dehydroxypaxilline

C27H33NO3 (419.2460308000001)

CDS1_000012

C26H33N3O2 (419.25726380000003)

Isohericerin

C27H33NO3 (419.2460308000001)

platencin SL4

C24H37NO3S (419.2494012000001)

CP-728663

C26H33N3O2 (419.25726380000003)

CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5898; ORIGINAL_PRECURSOR_SCAN_NO 5894 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5936; ORIGINAL_PRECURSOR_SCAN_NO 5934 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5937; ORIGINAL_PRECURSOR_SCAN_NO 5935 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5952; ORIGINAL_PRECURSOR_SCAN_NO 5951 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5960; ORIGINAL_PRECURSOR_SCAN_NO 5958 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5960; ORIGINAL_PRECURSOR_SCAN_NO 5959

Hericerin

C27H33NO3 (419.2460308000001)

1-Ethoxycarbonyl-d-phe-pro-2(4-aminobutyl)hydrazine

C21H33N5O4 (419.25324180000007)

Prenylamine lactate

C27H33NO3 (419.2460308000001)

Dtxcid9027283

C26H33N3O2 (419.25726380000003)

N-(2-Carboxyphenyl)retinamide

C27H33NO3 (419.2460308000001)

N-acetylsphingosine 1-phosphate(2-)

C20H38NO6P-2 (419.24366180000004)

N-[2-[1-[2-(4-methylphenoxy)ethyl]-2-benzimidazolyl]ethyl]cycloheptanecarboxamide

C26H33N3O2 (419.25726380000003)

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

N-[(5S,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

N-[(5S,6S,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

N-[(5S,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

N-[(4R,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

N-[(4S,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

N-[(4R,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

N-[(5R,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

N-[(5R,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

N-[(5R,6S,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

N-[(5R,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

N-[(4R,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

N-[(4S,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

N-[(4R,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

N-[(4S,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.24200880000006)

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.24200880000006)

HexCer 8:1;2O/6:0

C20H37NO8 (419.2519042)

HexCer 9:1;2O/5:0

C20H37NO8 (419.2519042)

HexCer 12:1;2O/2:0

C20H37NO8 (419.2519042)

HexCer 11:1;2O/3:0

C20H37NO8 (419.2519042)

HexCer 10:1;2O/4:0

C20H37NO8 (419.2519042)

ETHAMOXYTRIPHETOL

C27H33NO3 (419.2460308000001)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists

N-acetylsphingosine 1-phosphate(2-)

C20H38NO6P (419.24366180000004)

A N-acylsphingosine 1-phosphate(2-) in which the N-acyl group is specified as acetyl; major species at pH 7.3.

GLX481304

C23H29N7O (419.2433464)

GLX481304 is a specific inhibitor of Nox-2 and -4, with IC50s of 1.25 μM. GLX481304 suppresses ROS production in isolated mouse cardiomyocytes and improves cardiomyocyte contractility. GLX481304 can be used for research of ischemic injury to the heart[1].

6-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-7-hydroxy-5-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one

C27H33NO3 (419.2460308000001)

(1s,2r,5s,7r,8r,11s,14r)-1,2-dimethyl-7-(prop-1-en-2-yl)-6-oxa-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁶,²¹]tetracosa-9,15(23),16,18,20-pentaene-8,11-diol

C27H33NO3 (419.2460308000001)

6-(3,7-dimethylocta-2,6-dien-1-yl)-7-hydroxy-5-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one

C27H33NO3 (419.2460308000001)

(1s,2s,5s,7r,11r,14s)-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-8-one

C27H33NO3 (419.2460308000001)

1,2-dimethyl-7-(prop-1-en-2-yl)-6-oxa-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁶,²¹]tetracosa-9,15(23),16,18,20-pentaene-8,11-diol

C27H33NO3 (419.2460308000001)

n-[2-(4-{[(2e)-3-methyl-4-(3-methylbut-2-en-1-yl)-5-oxohex-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C27H33NO3 (419.2460308000001)

n-[2-(4-{[3-methyl-4-(3-methylbut-2-en-1-yl)-5-oxohex-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C27H33NO3 (419.2460308000001)

5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-6-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one

C27H33NO3 (419.2460308000001)

(3z,5e,12r,15e,17z,19z,21e,23z,25r)-2,12-dihydroxy-9,25-dimethyl-1-azacyclohexacosa-1,3,5,7,9,15,17,19,21,23-decaen-14-one

C27H33NO3 (419.2460308000001)

7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-8-one

C27H33NO3 (419.2460308000001)

5-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxy-6-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one

C27H33NO3 (419.2460308000001)